These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis. Gately S; Kerbel R Prog Exp Tumor Res; 2003; 37():179-92. PubMed ID: 12795055 [TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention. Menter DG Expert Opin Investig Drugs; 2002 Dec; 11(12):1749-64. PubMed ID: 12457435 [TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2: a therapeutic target. Turini ME; DuBois RN Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase inhibition in cancer prevention and treatment. Anderson WF; Umar A; Hawk ET Expert Opin Pharmacother; 2003 Dec; 4(12):2193-204. PubMed ID: 14640918 [TBL] [Abstract][Full Text] [Related]
6. Potential role of selective COX-2 inhibitors in cancer management. Dang CT; Shapiro CL; Hudis CA Oncology (Williston Park); 2002 May; 16(5 Suppl 4):30-6. PubMed ID: 12102578 [TBL] [Abstract][Full Text] [Related]
7. COX-2 inhibitors as radiosensitizing agents for cancer therapy. Davis TW; Hunter N; Trifan OC; Milas L; Masferrer JL Am J Clin Oncol; 2003 Aug; 26(4):S58-61. PubMed ID: 12902857 [TBL] [Abstract][Full Text] [Related]
9. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms. Nasir A; Fernandez PM; Chughtai OR; Kaiser HE In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894 [TBL] [Abstract][Full Text] [Related]
10. Celecoxib with chemotherapy in colorectal cancer. Blanke CD Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Subbaramaiah K; Dannenberg AJ Trends Pharmacol Sci; 2003 Feb; 24(2):96-102. PubMed ID: 12559775 [TBL] [Abstract][Full Text] [Related]
12. COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs. Moore BC; Simmons DL Curr Med Chem; 2000 Nov; 7(11):1131-44. PubMed ID: 11032963 [TBL] [Abstract][Full Text] [Related]
13. The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer. Crosby CG; DuBois RN Expert Opin Emerg Drugs; 2003 May; 8(1):1-7. PubMed ID: 14610907 [TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Gupta RA; Dubois RN Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248 [TBL] [Abstract][Full Text] [Related]
15. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer. Howe LR; Dannenberg AJ Semin Oncol; 2002 Jun; 29(3 Suppl 11):111-9. PubMed ID: 12138405 [TBL] [Abstract][Full Text] [Related]
16. The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition. Singh-Ranger G; Mokbel K Eur J Surg Oncol; 2002 Nov; 28(7):729-37. PubMed ID: 12431470 [TBL] [Abstract][Full Text] [Related]
17. Current application of selective COX-2 inhibitors in cancer prevention and treatment. Stratton MS; Alberts DS Oncology (Williston Park); 2002 May; 16(5 Suppl 4):37-51. PubMed ID: 12102579 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer. Yamamoto DS; Viale PH Clin J Oncol Nurs; 2003; 7(1):21-9. PubMed ID: 12629931 [TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenases and colon cancer. Kawai N; Tsujii M; Tsuji S Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():187-96. PubMed ID: 12432918 [TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet? Karamouzis MV; Papavassiliou AG Expert Opin Investig Drugs; 2004 Apr; 13(4):359-72. PubMed ID: 15102586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]